STOCK TITAN

Nuwellis (NASDAQ: NUWE) reports Q3 and nine-month 2025 results

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nuwellis, Inc. filed a report noting that on November 12, 2025 it released a press release with its financial results for the three and nine months ended September 30, 2025. The press release is included as Exhibit 99.1 and is incorporated by reference. The company states that this financial information is being furnished under Item 2.02 of Form 8-K, rather than filed, which limits how it is treated under certain securities law liability provisions.

Positive

  • None.

Negative

  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2025

Nuwellis, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-35312
No. 68-0533453
(State or Other Jurisdiction of Incorporation or Organization)
(Commission File Number)
(I.R.S. Employer Identification No.)

12988 Valley View Road, Eden Prairie, MN 55344
(Address of Principal Executive Offices) (Zip Code)

(952) 345-4200
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
NUWE
Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02
Results of Operations and Financial Condition.

On November 12, 2025, Nuwellis, Inc. (the “Company”) issued a press release reporting its financial results for the three and nine months ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information included in this Current Report on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits

Exhibit No. Description

99.1
Press Release, dated November 12, 2025, reporting the financial results of Nuwellis, Inc. for the three and nine months ended September 30, 2025.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 12, 2025
NUWELLIS, INC.
   
 
By:
/s/ John L. Erb
 
 
Name:
John L. Erb
 
 
Title:
President, Chief Executive Officer,
Interim Chief Financial Officer
 



FAQ

What did Nuwellis (NUWE) disclose in this Form 8-K?

Nuwellis disclosed that it issued a press release reporting its financial results for the three and nine months ended September 30, 2025, furnished as Exhibit 99.1.

Which period do the Nuwellis (NUWE) results in this update cover?

The results cover the three and nine months ended September 30, 2025.

Where can investors find the detailed Q3 2025 financial results for Nuwellis (NUWE)?

The detailed financial results are contained in the press release attached as Exhibit 99.1 to the report.

Is the Nuwellis (NUWE) financial information in this report considered filed with the SEC?

No. Nuwellis states the information, including Exhibit 99.1, is furnished under Item 2.02 and is not deemed filed for purposes of Section 18 of the Exchange Act.

What SEC item is Nuwellis (NUWE) using for this earnings disclosure?

Nuwellis is using Item 2.02, which covers results of operations and financial condition.

Who signed this Nuwellis (NUWE) Form 8-K?

The report was signed on behalf of Nuwellis, Inc. by John L. Erb, President, Chief Executive Officer, and Interim Chief Financial Officer.
Nuwellis Inc

NASDAQ:NUWE

View NUWE Stock Overview

NUWE Rankings

NUWE Latest News

NUWE Latest SEC Filings

NUWE Stock Data

1.89M
1.87M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
EDEN PRAIRIE